Primary |
Type 2 Diabetes Mellitus |
19.5% |
Diabetes Mellitus |
14.9% |
Insulin-requiring Type Ii Diabetes Mellitus |
11.9% |
Insulin-requiring Type 2 Diabetes Mellitus |
10.7% |
Hypertension |
9.3% |
Drug Use For Unknown Indication |
8.9% |
Product Used For Unknown Indication |
4.7% |
Type 1 Diabetes Mellitus |
4.5% |
Asthma |
2.2% |
Diabetes Mellitus Insulin-dependent |
2.0% |
Depression |
1.8% |
Blood Cholesterol Increased |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Ill-defined Disorder |
1.2% |
Cardiac Failure |
1.2% |
Prophylaxis |
1.1% |
Gastrooesophageal Reflux Disease |
0.9% |
Back Pain |
0.7% |
Cardiac Disorder |
0.7% |
Hypercholesterolaemia |
0.7% |
|
Blood Glucose Increased |
13.5% |
Hypoglycaemia |
9.6% |
Hypoglycaemic Unconsciousness |
7.8% |
Vomiting |
6.4% |
Vision Blurred |
6.0% |
Myocardial Infarction |
5.7% |
Loss Of Consciousness |
5.3% |
Urticaria |
5.3% |
Weight Increased |
4.6% |
Wrong Drug Administered |
4.6% |
Cerebrovascular Accident |
4.3% |
Product Quality Issue |
3.9% |
Death |
3.5% |
Palpitations |
3.2% |
Hypothermia |
2.8% |
Injection Site Urticaria |
2.8% |
Lower Limb Fracture |
2.8% |
Pneumonia |
2.8% |
Chest Pain |
2.5% |
Diabetes Mellitus Inadequate Control |
2.5% |
|
Secondary |
Type 2 Diabetes Mellitus |
25.0% |
Diabetes Mellitus |
16.8% |
Insulin-requiring Type 2 Diabetes Mellitus |
13.2% |
Drug Use For Unknown Indication |
9.2% |
Hypertension |
7.0% |
Insulin-requiring Type Ii Diabetes Mellitus |
6.5% |
Product Used For Unknown Indication |
6.3% |
Type 1 Diabetes Mellitus |
4.5% |
Cardiac Failure |
1.4% |
Prophylaxis |
1.3% |
Diabetes Mellitus Insulin-dependent |
1.2% |
Gastrooesophageal Reflux Disease |
1.2% |
Blood Cholesterol Increased |
1.1% |
Asthma |
1.0% |
Blood Pressure Abnormal |
1.0% |
Chronic Obstructive Pulmonary Disease |
1.0% |
Bone Pain |
0.7% |
Hernia |
0.7% |
Hyperuricaemia |
0.6% |
Arterial Spasm |
0.5% |
|
Hypoglycaemia |
12.2% |
Blood Glucose Increased |
11.6% |
Wrong Drug Administered |
9.5% |
Urinary Tract Infection |
5.4% |
Abortion Induced |
4.8% |
Diabetes Mellitus Inadequate Control |
4.8% |
Hypoglycaemic Unconsciousness |
4.8% |
Product Quality Issue |
4.8% |
Fall |
4.1% |
Injection Site Urticaria |
4.1% |
Palpitations |
4.1% |
Pneumonia |
4.1% |
Syncope |
4.1% |
Weight Increased |
4.1% |
Cerebral Infarction |
3.4% |
Urticaria |
3.4% |
Hypotension |
2.7% |
Intentional Overdose |
2.7% |
Medication Error |
2.7% |
Nausea |
2.7% |
|
Concomitant |
Drug Use For Unknown Indication |
19.6% |
Product Used For Unknown Indication |
19.0% |
Type 2 Diabetes Mellitus |
12.8% |
Diabetes Mellitus |
12.3% |
Hypertension |
9.8% |
Diabetes Mellitus Non-insulin-dependent |
3.1% |
Type 1 Diabetes Mellitus |
2.8% |
Prophylaxis |
2.8% |
Nuclear Magnetic Resonance Imaging |
2.6% |
Pain |
2.0% |
Depression |
1.7% |
Rheumatoid Arthritis |
1.6% |
Breast Cancer |
1.6% |
Insulin-requiring Type 2 Diabetes Mellitus |
1.4% |
Anxiety |
1.4% |
Osteoporosis |
1.3% |
Myocardial Ischaemia |
1.2% |
Sleep Disorder |
1.0% |
Stent Placement |
1.0% |
Insulin-requiring Type Ii Diabetes Mellitus |
0.9% |
|
Weight Decreased |
19.8% |
Vomiting |
13.8% |
Pancreatitis |
7.8% |
Syncope |
6.9% |
Weight Increased |
6.0% |
Oedema Mouth |
5.1% |
Nausea |
4.8% |
Renal Failure |
4.5% |
Blood Glucose Increased |
3.6% |
Somnolence |
3.3% |
Injection Site Pain |
3.0% |
Myocardial Infarction |
3.0% |
Thrombocytopenia |
3.0% |
Dyspnoea |
2.7% |
Death |
2.4% |
Rhabdomyolysis |
2.4% |
Cerebrovascular Accident |
2.1% |
Renal Failure Acute |
2.1% |
Tremor |
2.1% |
Lip Swelling |
1.8% |
|
Interacting |
Hypertension |
24.5% |
Diabetes Mellitus |
17.0% |
Type 1 Diabetes Mellitus |
17.0% |
Type 2 Diabetes Mellitus |
13.2% |
Diabetes Insipidus |
7.5% |
Podagra |
5.7% |
Renal Failure |
5.7% |
Renal Failure Chronic |
5.7% |
Drug Use For Unknown Indication |
3.8% |
|
Renal Failure |
40.0% |
Malaise |
30.0% |
Hypoglycaemia |
20.0% |
Hypothermia |
10.0% |
|